Pairing this with our finding that PTDSS1 is frequently amplified across diverse tumor types and associates with poor patient survival, these results indicates that PTDSS1 represents a broadly relevant target for developing novel cancer therapeutic strategies. Here, PTDSS1 is linked to cancer.